Table 3. Univariate and multivariate analyses for predicting liver fibrosis stage ≥2 and 3.

	P	Univariate		P	Multivariate
		Odds ratio	95% CI		Odds ratio	95% CI
Fibrosis stage ≥ 2
WFA-M2BP	< 0.001	5.182	2.096–12.81	0.050	3.790	1.005–14.46
ELF	< 0.001	2.109	1.479–3.008	0.030	1.994	1.071–3.714
Fibroscan	0.031	1.102	1.009–1.204	NS
FIB-4	0.042	4.574	1.053–19.86	NS
APRI	0.044	1.594	1.012–2.510	NS
Albumin	NS			NS
ALT	NS			NS
AST	NS			NS
Hemoglobin	NS			NS
Prothrombin Time	0.001	2.618	1.452–4.718	NS
Platelet	< 0.001	0.986	0.978–0.994	0.023	0.987	0.976–0.998
HBsAg	NS			NS
Fibrosis stage 3
WFA-M2BP	0.01	1.784	1.152–2.764	NS
ELF score	0.018	1.616	1.085–2.406	NS
Fibroscan	0.006	1.095	1.026–1.168	NS
FIB-4	NS			NS
APRI	NS			NS
Albumin	NS			NS
ALT	NS			NS
AST	NS			NS
Hemoglobin	NS			NS
Prothrombin Time	0.049	1.207	1.001–1.455	NS
Platelet	0.011	0.982	0.968–0.996	0.037	0.502	0.117–2.160
HBsAg	NS			NS

Abbreviations: CI, confidence interval; WFA-M2BP, Wisteria floribunda agglutinin-positive Mac-2 binding protein; APRI, AST-to-platelet ratio; ELF, enhanced liver fibrosis; HBsAg, hepatitis B surface antigen; NS, not significant.